- Home
- OPK vs CDNA Comparison
OPK vs CDNA Comparison
Compare OPK & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPK
- CDNA
- Stock Information
- Founded
- OPK 2007
- CDNA 1998
- Country
- OPK United States
- CDNA United States
- Employees
- OPK N/A
- CDNA N/A
- Industry
- OPK Biotechnology: Pharmaceutical Preparations
- CDNA Medical Specialities
- Sector
- OPK Health Care
- CDNA Health Care
- Exchange
- OPK Nasdaq
- CDNA Nasdaq
- Market Cap
- OPK 1.3B
- CDNA 1.1B
- IPO Year
- OPK 1995
- CDNA 2014
- Fundamental
- Price
- OPK $1.61
- CDNA $17.14
- Analyst Decision
- OPK Strong Buy
- CDNA Buy
- Analyst Count
- OPK 3
- CDNA 8
- Target Price
- OPK $2.75
- CDNA $29.43
- AVG Volume (30 Days)
- OPK 3.9M
- CDNA 628.1K
- Earning Date
- OPK 05-06-2025
- CDNA 05-08-2025
- Dividend Yield
- OPK N/A
- CDNA N/A
- EPS Growth
- OPK N/A
- CDNA N/A
- EPS
- OPK N/A
- CDNA 0.93
- Revenue
- OPK $713,142,000.00
- CDNA $333,785,000.00
- Revenue This Year
- OPK N/A
- CDNA $13.33
- Revenue Next Year
- OPK $8.11
- CDNA $15.07
- P/E Ratio
- OPK N/A
- CDNA $19.51
- Revenue Growth
- OPK N/A
- CDNA 19.07
- 52 Week Low
- OPK $1.15
- CDNA $7.42
- 52 Week High
- OPK $2.04
- CDNA $34.84
- Technical
- Relative Strength Index (RSI)
- OPK 36.29
- CDNA 37.05
- Support Level
- OPK $1.60
- CDNA $16.98
- Resistance Level
- OPK $1.80
- CDNA $18.51
- Average True Range (ATR)
- OPK 0.06
- CDNA 0.78
- MACD
- OPK -0.03
- CDNA 0.01
- Stochastic Oscillator
- OPK 3.93
- CDNA 11.59
Stock Price Comparison Chart: OPK vs CDNA
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.